Tevimbra

tislelizumab-jsgr

Approval

ApplicationBLA 761232
Approval dateMar 13, 2024
Approval year2024
SponsorBeigene

FDA-approved use

To treat unresectable or metastatic esophageal squamous cell carcinoma

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Tevimbra: